2,082
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Anti-tumour effects of TRAIL-expressing human placental derived mesenchymal stem cells with curcumin-loaded chitosan nanoparticles in a mice model of triple negative breast cancer

, , , , &
Pages 1011-1021 | Received 23 Jul 2018, Accepted 13 Sep 2018, Published online: 24 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mian Huang, Bing-Tao Zhai, Yu Fan, Jing Sun, Ya-Jun Shi, Xiao-Fei Zhang, Jun-Bo Zou, Jia-Wen Wang & Dong-Yan Guo. (2023) Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy. International Journal of Nanomedicine 18, pages 4275-4311.
Read now
Pawaret Panyajai, Singkome Tima, Sawitree Chiampanichayakul & Songyot Anuchapreeda. (2019) Dietary Turmeric Bisdemethoxycurcumin Suppresses Wilms’ Tumor 1 and CD34 Protein Expressions in KG-1a Leukemic Stem Cells. Nutrition and Cancer 71:7, pages 1189-1200.
Read now

Articles from other publishers (23)

Arti Shettiwar, Ujala Gupta, Priti Paul, Rahul Nair, Mayur Aalhate, Srushti Mahajan, Indrani Maji, Santosh Kumar Guru, Neelesh Kumar Mehra & Pankaj Kumar Singh. (2023) A comprehensive review of the biomaterial-based multifunctional nanocarriers for therapeutic applications in breast cancer. Journal of Drug Delivery Science and Technology 89, pages 104990.
Crossref
Tarun Virmani, Girish Kumar, Ashwani Sharma, Kamla Pathak, Md Sayeed Akhtar, Obaid Afzal & Abdulmalik S. A. Altamimi. (2023) Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates. Polymers 15:13, pages 2928.
Crossref
Yong Wu, Hang Chee Erin Shum, Ke Wu & Jaydutt Vadgama. (2023) From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer. Biomedicines 11:4, pages 1182.
Crossref
Bhuvi Sachdeva, Punya Sachdeva, Arvind Negi, Shampa Ghosh, Sungsoo Han, Saikat Dewanjee, Saurabh Kumar Jha, Rakesh Bhaskar, Jitendra Kumar Sinha, Ana Cláudia Paiva-Santos, Niraj Kumar Jha & Kavindra Kumar Kesari. (2023) Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges. Marine Drugs 21:4, pages 211.
Crossref
Mohsen Karami Fath, Zahra Moayedi Banan, Reza Barati, Omid Mohammadrezakhani, Aliasghar Ghaderi, Ali Hatami, Shamim Ghiabi, Nazanin Zeidi, Katayoon Asgari, Zahra Payandeh & Ghasem Barati. (2023) Recent advancements to engineer mesenchymal stem cells and their extracellular vesicles for targeting and destroying tumors. Progress in Biophysics and Molecular Biology 178, pages 1-16.
Crossref
Manjari Kundu, Yoshimi Endo Greer, Jennifer L. Dine & Stanley Lipkowitz. (2022) Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy. Cells 11:23, pages 3717.
Crossref
Antonietta R. Silini, Taja Železnik Ramuta, Ana Salomé Pires, Asmita Banerjee, Marie Dubus, Florelle Gindraux, Halima Kerdjoudj, Justinas Maciulatis, Adelheid Weidinger, Susanne Wolbank, Günther Eissner, Bernd Giebel, Michela Pozzobon, Ornella Parolini & Mateja Erdani Kreft. (2022) Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and antimicrobial applications. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Ricardo Teixo, Ana Salomé Pires, Eurico Pereira, Beatriz Serambeque, Inês Alexandra Marques, Mafalda Laranjo, Slavko Mojsilović, Roberto Gramignoli, Peter Ponsaerts, Andreina Schoeberlein & Maria Filomena Botelho. (2022) Application of Perinatal Derivatives on Oncological Preclinical Models: A Review of Animal Studies. International Journal of Molecular Sciences 23:15, pages 8570.
Crossref
Tianyuan Zhang, Ruyi Lin, Honghui Wu, Xinchi Jiang & Jianqing Gao. (2022) Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Advanced Drug Delivery Reviews 185, pages 114300.
Crossref
Shima Lotfollahzadeh, Elaheh Sadat Hosseini, Hooman Mahmoudi Aznaveh, Maryam Nikkhah & Saman Hosseinkhani. (2022) TRAIL/S-layer/graphene quantum dot nanohybrid enhanced stability and anticancer activity of TRAIL on colon cancer cells. Scientific Reports 12:1.
Crossref
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, John D. Schneible, Iman Fatemi, Abdolsamad Shirvani, Ali Zarrabi, Fereshteh Azedi, Ali Dehshahri, Abbas Aghaei Afshar, Kian Aghaabbasi, Abbas Pardakhty, Reza Mohammadinejad & Prashant Kesharwani. (2022) Chitosan: A versatile bio-platform for breast cancer theranostics. Journal of Controlled Release 341, pages 733-752.
Crossref
Kumar Ganesan, Yan Wang, Fei Gao, Qingqing Liu, Chen Zhang, Peng Li, Jinming Zhang & Jianping Chen. (2021) Targeting Engineered Nanoparticles for Breast Cancer Therapy. Pharmaceutics 13:11, pages 1829.
Crossref
Kamal Shaik Fakiruddin, Moon Nian Lim, Norshariza Nordin, Rozita Rosli & Syahril Abdullah. (2021) Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines. Biology 10:11, pages 1103.
Crossref
Ehsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, Dmitry O. Bokov, Walid Kamal Abdelbasset, Ali Hassanzadeh, Faroogh Marofi, Mahboubeh Yazdanifar & Mostafa Jarahian. (2021) Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges. Frontiers in Immunology 12.
Crossref
Qiaobin Hu & Yangchao Luo. (2021) Chitosan-based nanocarriers for encapsulation and delivery of curcumin: A review. International Journal of Biological Macromolecules 179, pages 125-135.
Crossref
Gloria María Pontes-Quero, Lorena Benito-Garzón, Juan Pérez Cano, María Rosa Aguilar & Blanca Vázquez-Lasa. (2021) Amphiphilic polymeric nanoparticles encapsulating curcumin: Antioxidant, anti-inflammatory and biocompatibility studies. Materials Science and Engineering: C 121, pages 111793.
Crossref
Madhu Rani, Sumit Kumar & M. Moshahid Alam Rizvi. 2021. Handbook of Research on Advancements in Cancer Therapeutics. Handbook of Research on Advancements in Cancer Therapeutics 467 485 .
Flavia Fontana, Raquél Bartolo & Hélder A. Santos. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy 135 162 .
Mohammad Kamalabadi-Farahani & Vahid Kia. (2020) High percentage of cancer stem cells in metastatic locations; a comment on a claim “variation in cancer risk among tissues can be explained by the number of stem cell divisions”. Medical Hypotheses 144, pages 110170.
Crossref
Shivaprasad Gadag, Shristi Sinha, Yogendra Nayak, Sanjay Garg & Usha Y. Nayak. (2020) Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer. Pharmaceutics 12:6, pages 524.
Crossref
Rama Rao Malla, KGK Deepak, Neha Merchant & Venkata Ramesh Dasari. (2020) Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals. Phytomedicine 70, pages 153227.
Crossref
Fatemeh Rahimi-Sherbaf, Samad Nadri, Ali Rahmani & Atousa Dabiri Oskoei. (2020) Placenta mesenchymal stem cells differentiation toward neuronal-like cells on nanofibrous scaffold. BioImpacts 10:2, pages 117-122.
Crossref
Kamal Shaik Fakiruddin, Moon Lim, Norshariza Nordin, Rozita Rosli, Zubaidah Zakaria & Syahril Abdullah. (2019) Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer. Cancers 11:9, pages 1261.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.